Insider · CIK 0001518466

Janda Kim

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001518466

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-12-27	Sorrento Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$4.00	+$12K	6,000
2021-12-27	Sorrento Therapeutics, Inc.S Sale	Director	SSale	−3,000 sh	$5.88	−$17.6K	3,000
2021-12-27	Sorrento Therapeutics, Inc.Non-qualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	0
2021-09-27	Sorrento Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+35K sh	$1.80	+$63K	38,000
2021-09-27	Sorrento Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,357 sh	$3.57	+$26.3K	45,357
2021-09-27	Sorrento Therapeutics, Inc.S Sale	Director	SSale	−42.4K sh	$8.02	−$340K	3,000
2021-09-27	Sorrento Therapeutics, Inc.Stock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−35K sh	—	—	0
2021-09-27	Sorrento Therapeutics, Inc.Stock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−7,357 sh	—	—	27,643
2021-09-13	Sorrento Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,000 sh	$3.50	+$28K	11,000
2021-09-13	Sorrento Therapeutics, Inc.S Sale	Director	SSale	−8,000 sh	$8.04	−$64.3K	3,000
2021-09-13	Sorrento Therapeutics, Inc.Non-qualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−8,000 sh	—	—	0
2021-08-30	Sorrento Therapeutics, Inc.Stock option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000
2021-04-12	Sorrento Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,900 sh	$3.50	+$6,650	4,900
2021-04-12	Sorrento Therapeutics, Inc.S Sale	Director	SSale	−1,900 sh	$6.97	−$13.3K	3,000
2021-04-12	Sorrento Therapeutics, Inc.Non-qualified stock optionM Exercise/Conversion	Director	MExercise/Conversion	−1,900 sh	—	—	0
2021-03-15	Sorrento Therapeutics, Inc.S Sale	Director	SSale	−3,000 sh	$10.42	−$31.3K	0
2020-08-07	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+150K sh	—	—	150,000
2020-06-15	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+100K sh	—	—	100,000
2019-04-19	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+70K sh	—	—	70,000
2018-11-26	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2017-09-15	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2017-09-15	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2017-02-03	Sorrento Therapeutics, Inc.P Purchase	Director	PPurchase	+3,000 sh	$5.15	+$15.5K	3,000
2016-07-11	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+35K sh	—	—	132,400
2015-06-04	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+28K sh	—	—	97,400
2014-09-18	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+12.5K sh	—	—	69,400
2014-01-23	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+10K sh	—	—	56,900
2013-10-29	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+9,000 sh	—	—	46,900
2012-10-17	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+400K sh	—	—	400,000
2012-07-20	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+25K sh	—	—	25,000
2012-02-06	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+75K sh	—	—	75,000
2011-09-28	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+200K sh	—	—	200,000
2011-04-15	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+47.5K sh	—	—	47,500

Recent filings

Accepted (ET)
Feb 65
Janda Kim0001209191-23-007395
SEC(opens sec.gov)
Dec 274
Janda Kim0001209191-21-071311
SEC(opens sec.gov)
Sep 284
Janda Kim0001209191-21-057957
SEC(opens sec.gov)
Sep 144
Janda Kim0001209191-21-055954
SEC(opens sec.gov)
Aug 304
Janda Kim0001209191-21-053982
SEC(opens sec.gov)
Apr 154
Janda Kim0001209191-21-026867
SEC(opens sec.gov)
Aug 144
Janda Kim0000850261-20-000049
SEC(opens sec.gov)
Jun 154
Janda Kim0000850261-20-000041
SEC(opens sec.gov)
Apr 234
Janda Kim0000850261-19-000014
SEC(opens sec.gov)
Nov 274
Janda Kim0000850261-18-000042
SEC(opens sec.gov)

Companies

Sorrento Therapeutics, Inc.Director

Address

C/O SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT. W, SUITE B

SAN DIEGO, CA, 92121